Showing 421 to 432 of 1,191 results
Wisconsin Man Dies After Inhaler Price Surge
A 22-year-old Wisconsin man, Cole Schmidtknecht, died from an asthma attack after his inhaler's price increased from $66 to $539 due to OptumRx, a UnitedHealth Group subsidiary, ending coverage; his parents are suing OptumRx, Walgreens, and Boots Alliance for negligence.
Wisconsin Man Dies After Inhaler Price Surge
A 22-year-old Wisconsin man, Cole Schmidtknecht, died from an asthma attack after his inhaler's price increased from $66 to $539 due to OptumRx, a UnitedHealth Group subsidiary, ending coverage; his parents are suing OptumRx, Walgreens, and Boots Alliance for negligence.
Progress
52% Bias Score
Doctors Sue Federal Agencies Over Removal of Health Data
Doctors for America sued the OPM, CDC, FDA, and HHS for removing health-related webpages and data, citing risks to patient care and research, alleging the removals stemmed from an OPM memorandum referencing President Trump's executive order on gender ideology.
Doctors Sue Federal Agencies Over Removal of Health Data
Doctors for America sued the OPM, CDC, FDA, and HHS for removing health-related webpages and data, citing risks to patient care and research, alleging the removals stemmed from an OPM memorandum referencing President Trump's executive order on gender ideology.
Progress
32% Bias Score
China's Coordinated Push for Brain-Computer Interface Dominance
China's National Medical Products Administration is drafting standards for BCI medical devices, while Beijing and Shanghai aim to cultivate globally influential BCI tech leaders by 2030, reflecting a national push to transition BCI technology from exploration to implementation, with a market project...
China's Coordinated Push for Brain-Computer Interface Dominance
China's National Medical Products Administration is drafting standards for BCI medical devices, while Beijing and Shanghai aim to cultivate globally influential BCI tech leaders by 2030, reflecting a national push to transition BCI technology from exploration to implementation, with a market project...
Progress
36% Bias Score
Queensland Satellite Hospitals Renamed Amidst Opposition Criticism
The Crisafulli government will rename Queensland's seven satellite hospitals to satellite health centers at a cost exceeding \$200,000, prompting criticism from the opposition for prioritizing image over service expansion.
Queensland Satellite Hospitals Renamed Amidst Opposition Criticism
The Crisafulli government will rename Queensland's seven satellite hospitals to satellite health centers at a cost exceeding \$200,000, prompting criticism from the opposition for prioritizing image over service expansion.
Progress
44% Bias Score
Cramer's Trust Books Profits on Abbott Labs Stock After 12% Surge
Jim Cramer's Charitable Trust sold 50 shares of Abbott Laboratories (ABT) at ~$131.67 on Wednesday, decreasing its holdings to 650 shares (2.33% weighting) after a recent 12% price surge driven by strong sales projections and resolved legal issues, resulting in a roughly 16% gain on shares purchased...
Cramer's Trust Books Profits on Abbott Labs Stock After 12% Surge
Jim Cramer's Charitable Trust sold 50 shares of Abbott Laboratories (ABT) at ~$131.67 on Wednesday, decreasing its holdings to 650 shares (2.33% weighting) after a recent 12% price surge driven by strong sales projections and resolved legal issues, resulting in a roughly 16% gain on shares purchased...
Progress
48% Bias Score
Influenza Surge in Bavaria Overwhelms Schools
Over 15,000 influenza cases have been reported in Bavaria this winter, impacting schools severely due to high infection rates among children and teachers, leading to increased absences and remote learning in some cases.
Influenza Surge in Bavaria Overwhelms Schools
Over 15,000 influenza cases have been reported in Bavaria this winter, impacting schools severely due to high infection rates among children and teachers, leading to increased absences and remote learning in some cases.
Progress
24% Bias Score
AI Finds Life-Saving Drug for Terminally Ill Patient
An AI identified adalimumab, a drug used for arthritis and Crohn's disease, as a life-saving treatment for a terminally ill patient with idiopathic multicentric Castleman's disease (iMCD), who is now in remission almost two years after entering hospice care.
AI Finds Life-Saving Drug for Terminally Ill Patient
An AI identified adalimumab, a drug used for arthritis and Crohn's disease, as a life-saving treatment for a terminally ill patient with idiopathic multicentric Castleman's disease (iMCD), who is now in remission almost two years after entering hospice care.
Progress
40% Bias Score
Chinese Scientist Wins Prestigious Stroke Research Award
Chinese clinical scientist Wang Yongjun received the 2025 William M. Feinberg Award for Excellence in Clinical Stroke at the International Stroke Conference in Los Angeles for his 30 years of research resulting in 12 key pieces of evidence changing clinical guidelines and practice in intravenous thr...
Chinese Scientist Wins Prestigious Stroke Research Award
Chinese clinical scientist Wang Yongjun received the 2025 William M. Feinberg Award for Excellence in Clinical Stroke at the International Stroke Conference in Los Angeles for his 30 years of research resulting in 12 key pieces of evidence changing clinical guidelines and practice in intravenous thr...
Progress
28% Bias Score
Toronto Hospital Tackles Homelessness and Staff Housing Crisis
The University Health Network (UHN) in Toronto launched two housing projects: a 51-unit transitional housing project for frequent ER users and a 100-unit affordable housing complex for its employees, addressing issues of homelessness, addiction, and staff retention.
Toronto Hospital Tackles Homelessness and Staff Housing Crisis
The University Health Network (UHN) in Toronto launched two housing projects: a 51-unit transitional housing project for frequent ER users and a 100-unit affordable housing complex for its employees, addressing issues of homelessness, addiction, and staff retention.
Progress
36% Bias Score
Lawsuit Challenges Trump's Ban on Transgender Healthcare Funding for Minors
LGBTQ+ advocates and families sued the Trump administration for banning federal funding of transgender healthcare for minors, citing the executive order as unconstitutional and causing immediate disruptions in care, while a legal expert predicts further legal challenges.
Lawsuit Challenges Trump's Ban on Transgender Healthcare Funding for Minors
LGBTQ+ advocates and families sued the Trump administration for banning federal funding of transgender healthcare for minors, citing the executive order as unconstitutional and causing immediate disruptions in care, while a legal expert predicts further legal challenges.
Progress
80% Bias Score
Oscar Health Reports First Annual Profit, Driven by Record Enrollment Growth
Oscar Health reported a $25 million profit for 2024, a significant turnaround from a $270 million loss in 2023, driven by record enrollment growth (nearly 1.7 million members) and a 56% increase in revenue to $9.1 billion. The company anticipates further growth in 2025, projecting revenue between $1...
Oscar Health Reports First Annual Profit, Driven by Record Enrollment Growth
Oscar Health reported a $25 million profit for 2024, a significant turnaround from a $270 million loss in 2023, driven by record enrollment growth (nearly 1.7 million members) and a 56% increase in revenue to $9.1 billion. The company anticipates further growth in 2025, projecting revenue between $1...
Progress
48% Bias Score
Widespread Fraud Delays Alzheimer's Cure
Investigative journalist Charles Piller's book, "Doctored," exposes widespread fraud in Alzheimer's research, revealing fabricated results, manipulated images, and regulatory failures costing hundreds of millions of dollars and delaying potential cures; the cases of Lesné and Ashe, and Cassava Scien...
Widespread Fraud Delays Alzheimer's Cure
Investigative journalist Charles Piller's book, "Doctored," exposes widespread fraud in Alzheimer's research, revealing fabricated results, manipulated images, and regulatory failures costing hundreds of millions of dollars and delaying potential cures; the cases of Lesné and Ashe, and Cassava Scien...
Progress
48% Bias Score
Showing 421 to 432 of 1,191 results